Arginine and Whole Brain Radiation Therapy for Brain Metastases
EARLY_PHASE1
10
about 3.3 years
18+
1 site in GA
What this study is about
This trial is testing different ways to give arginine, either by mouth or through a vein, along with whole-brain radiation therapy in people who have cancer that has spread to the brain. The goal is to determine if giving arginine improves how well brain metastases respond to radiation and to find the best way to administer it.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Arginine
- 2.Receive Whole-Brain Radiotherapy
- 3.Undergo Biospecimen Collection
- +3 more
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You are randomly assigned, but you will know your treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Therapeutic Nutrients/Minerals/Electrolytes (Biological Macromolecular Activity)
oral (Oral Capsule)
Secondary: Incidence of adverse events associated with delivering L-arginine with standard fractionation whole brain radiation therapy
diagnostic, imaging, radiation